← Earnings Calendar
Coverage News Earnings Hub Grades Earnings Report
NKTR Q1 2026
Nektar Therapeutics
Pharmaceuticals
—
No Grade
⚠️
Significant Miss
Actual $-1.82 vs Est $-1.63
-11.9%
📊 EPS Scorecard
EPS Estimate
$-1.63
EPS Actual
$-1.82
Surprise
-11.9%
Period2026-03-31
QuarterQ1 2026
📈 EPS Momentum — Last 4 Quarters
$-2.95
25-06
$-1.87
25-09
$-1.78
25-12
$-1.82
26-03
📈 +38% over 4 quarters
🤖 ESEN AI Grade Reasoning
🔒 AI Grade Reasoning Unlock with PLUS
🔗 Other NKTR Earnings
NKTR
Q2 2026
→ View
NKTR
Q3 2026
→ View
NKTR
Q4 2026
→ View
NKTR
Full Research
→ Stock Page
Unlock Full Earnings Analysis
AI grade reasoning, momentum alerts, and full analysis for 5,000+ stocks
Start PLUS — First Month $4.99
Then $19.99/month · Cancel anytime